EPCAM and ovarian carcinoma: Similar approaches and analytical techniques for exosome protein typing have been developed: Using the NanoSight LM10 equipped with a 405 nm blue-violet laser, Gercel-Taylor et al. demonstrated that antibodies against either CD63 or EpCAM labelled with quantum dots could be used to phenotype exosomes purified from patients with ovarian cancer (27).